Ravi Panjabi, MD
Anesthesiology · Castro Valley, CANPI 1225024219
Payments from drug & device makers
Across 420 payments — averaging $50.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stimwave Technologies Incorporated$7K
- Painteq LLC$2K
- Omnia Medical, LLC$2K
- Abbott$1K
- Surgentec$1K
- Curonix LLC$894
- plus $7K from 40 others
What the payments were for
- Consulting fees$1,6008%
- Travel & lodging$7,66236%
- Food & beverage$10,30049%
- Education$5983%
- Gifts$2391%
- Entertainment$7914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PAINTEQ$1,195
- ION Facet Screw$1,183
- IFUSE IMPLANT SYSTEM$554
- VenaSeal$485
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$449
- mild Device Kit$363
- Nalu Neurostimulation System$311
- SCS FreedonSpinal Cord Stimulator$237
- SPRINT PNS System$208
- Senza$174
- Neuromodulation Dspsbls and Accs$162
- Proclaim IPG$133
- StimQ Peripheral Nerve StimulatorSystem$123
- WaveWriter Alpha Prime 16$118
- Neurostimulation$114
- ClosureFast$108
How this compares
$21,190 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $6,025 |
| Buprenorphine | 15 | $3,401 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 101 | $2,482 |
| Morphine Sulfate ErMorphine Sulfate | 32 | $2,020 |
| Celecoxib | 20 | $1,932 |
| Lidocaine | 18 | $1,870 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 64 | $1,369 |
| Pregabalin | 40 | $1,040 |
| Diclofenac Sodium | 30 | $865 |
| Gabapentin | 49 | $587 |
| Oxycodone Hcl | 22 | $568 |
| Methadone Hcl | 16 | $418 |
| Morphine Sulfate | 25 | $307 |
| Cyclobenzaprine Hcl | 20 | $304 |
| Duloxetine Hcl | 19 | $228 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Castro Valley
- Kamal MaheshwariSacramento$1.9M
- Gregory HammerStanford$1.8M
- Neal FlemingSacramento$1.7M
- Joseph AntogniniSacramento$1.4M
- Daniel NguyenDuarte$1.4M
- Jack JengSouth San Francisco$1.3M
- Eilon GabelLos Angeles$1.2M
- Philip BicklerSan Francisco$853K
- Joseph RinehartNewport Beach$824K
- Richard Applegate IiLoma Linda$810K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.